M.D. Gardner

2.9k total citations
20 papers, 422 citations indexed

About

M.D. Gardner is a scholar working on Oncology, Nephrology and Orthopedics and Sports Medicine. According to data from OpenAlex, M.D. Gardner has authored 20 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Nephrology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in M.D. Gardner's work include Bone health and treatments (7 papers), Bone and Joint Diseases (5 papers) and Parathyroid Disorders and Treatments (4 papers). M.D. Gardner is often cited by papers focused on Bone health and treatments (7 papers), Bone and Joint Diseases (5 papers) and Parathyroid Disorders and Treatments (4 papers). M.D. Gardner collaborates with scholars based in United Kingdom, Canada and United States. M.D. Gardner's co-authors include Stuart H. Ralston, Richard Cowan, F.J. Dryburgh, I.T. Boyle, Andrew Jenkins, R. Scott, I. Fogelman, I. T. Boyle, Aus Alzaid and S.H. Ralston and has published in prestigious journals such as The Lancet, Clinical Chemistry and Epilepsia.

In The Last Decade

M.D. Gardner

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.D. Gardner United Kingdom 9 289 144 122 72 62 20 422
Sören Jakobsson Sweden 9 212 0.7× 104 0.7× 81 0.7× 396 5.5× 91 1.5× 12 654
A.M. Galich Argentina 10 430 1.5× 539 3.7× 61 0.5× 116 1.6× 212 3.4× 24 778
Tove Skjelbakken Norway 11 176 0.6× 29 0.2× 60 0.5× 18 0.3× 26 0.4× 23 434
Jianhong Zhu China 10 136 0.5× 33 0.2× 174 1.4× 16 0.2× 85 1.4× 43 546
E Jacobs Netherlands 8 71 0.2× 34 0.2× 37 0.3× 18 0.3× 27 0.4× 14 296
Ana Balske United States 7 647 2.2× 814 5.7× 22 0.2× 36 0.5× 351 5.7× 7 986
Marcin Krzanowski Poland 12 56 0.2× 33 0.2× 36 0.3× 126 1.8× 72 1.2× 56 370
Claudia Friedl Austria 10 45 0.2× 80 0.6× 72 0.6× 113 1.6× 145 2.3× 19 544
D. Morgan United States 8 58 0.2× 165 1.1× 16 0.1× 64 0.9× 34 0.5× 16 376
R Correa-Rotter Mexico 10 94 0.3× 19 0.1× 45 0.4× 160 2.2× 60 1.0× 24 381

Countries citing papers authored by M.D. Gardner

Since Specialization
Citations

This map shows the geographic impact of M.D. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Gardner more than expected).

Fields of papers citing papers by M.D. Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Gardner. The network helps show where M.D. Gardner may publish in the future.

Co-authorship network of co-authors of M.D. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of M.D. Gardner. A scholar is included among the top collaborators of M.D. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.D. Gardner. M.D. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gardner, M.D., Paul J. Godley, & Suman Wasan. (1990). Sodium Loading Treatment for Amphotericin B-Induced Nephrotoxicity. DICP. 24(10). 940–946. 19 indexed citations
2.
Alzaid, Aus, et al.. (1988). Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate. Postgraduate Medical Journal. 64(749). 224–227. 7 indexed citations
3.
Wilson, Colin, Fraser Wd, M.D. Gardner, & C W Imrie. (1987). Source of lactate dehydrogenase elevation in acute pancreatitis. Digestion. 38(1). 64. 1 indexed citations
5.
Ralston, S H, et al.. (1986). Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.. Journal of Clinical Pathology. 39(6). 641–646. 5 indexed citations
6.
Henderson, A R & M.D. Gardner. (1986). Patients with suspected myocardial infarction: their test request patterns for clinical biochemistry in a British and a Canadian cardiac care unit.. Journal of Clinical Pathology. 39(7). 803–807. 6 indexed citations
7.
Ralston, Stuart H., et al.. (1986). Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.. BMJ. 292(6535). 1549–1550. 51 indexed citations
8.
Ralston, S H, Brendan F. Boyce, Richard Cowan, et al.. (1986). Humoral Hypercalcaemia of Malignancy: Metabolic and Histomorphometric Studies During Surgical Management of the Primary Tumour. QJM. 11 indexed citations
9.
Ralston, Stuart H., F.J. Dryburgh, Richard Cowan, et al.. (1985). COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIA. The Lancet. 326(8461). 907–910. 146 indexed citations
10.
Lesser, Ronald P., et al.. (1984). Enhanced Gastrointestinal Excretion of Phenytoin in a Patient with Crohn's Disease. Epilepsia. 25(3). 302–307. 2 indexed citations
11.
Ralston, S.H., I. Fogelman, M.D. Gardner, et al.. (1984). Hypercalcaemia of Malignancy: Evidence for a Non-Parathyroid Humoral Agent with An Effect on Renal Tubular Handling of Calcium. Clinical Science. 66(2). 187–191. 61 indexed citations
12.
Gardner, M.D. & A R Henderson. (1983). Test-request patterns for clinical chemistry in a British and a Canadian renal dialysis unit.. Clinical Chemistry. 29(8). 1546–1548. 2 indexed citations
13.
Ralston, Stuart H., M.D. Gardner, I. Fogelman, & I.T. Boyle. (1982). HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?. The Lancet. 320(8304). 903–905. 30 indexed citations
14.
Christensson, T., F.J. Dryburgh, & M.D. Gardner. (1982). CALCIUM AND BLOOD PRESSURE. The Lancet. 319(8280). 1076–1077. 1 indexed citations
15.
Fogelman, I., James M. Gray, M.D. Gardner, et al.. (1982). Do Anticonvulsant Drugs Commonly Induce Osteomalacia?. Scottish Medical Journal. 27(2). 136–142. 10 indexed citations
16.
Henderson, A R & M.D. Gardner. (1981). Clinical chemistry laboratory productivity: a comparison between a Canadian and a British teaching hospital.. Journal of Clinical Pathology. 34(1). 44–48. 4 indexed citations
17.
Jenkins, Andrew, et al.. (1980). An evaluation of the Nova 2 ionised calcium instrument. Journal of Analytical Methods in Chemistry. 2(2). 85–89. 7 indexed citations
18.
Gardner, M.D. & R. Scott. (1980). Age- and sex-related reference ranges for eight plasma constituents derived from randomly selected adults in a Scottish new town.. Journal of Clinical Pathology. 33(4). 380–385. 34 indexed citations
19.
Gardner, M.D. & R. Scott. (1978). Frequency distribution and 'reference values' of plasma alkaline phosphatase (EC 3.1.3.1) activity in the adult population of a Scottish new town.. Journal of Clinical Pathology. 31(12). 1202–1206. 13 indexed citations
20.
Boder, Elena, et al.. (1974). Congenital and genetic skin disorders with tumor formation.. PubMed. 10(4). 265–84. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026